Nicotine letter
This article was originally published in The Tan Sheet
Executive Summary
The "public health imperative" that led FDA to prohibit sale of nicotine lollipops "should lead to the same swift and decisive action with regard" to other unconventional nicotine products, 11 public health groups assert in April 19 letter to FDA. "While we recognize that no two products are exactly alike," agency's purview over novel nicotine delivery vehicles is "as strong as the authority that it exercised to prohibit the sale of nicotine lollipops," letter states. FDA recently targeted four Internet pharmacies selling nicotine pops, lip balms (1"The Tan Sheet" April 15, 2002, p. 7). Letter, signed by health groups such as AMA, AHA, Campaign for Tobacco-Free Kids, references their Dec. 18 petition urging FDA to regulate nicotine lozenges, water as either foods or drugs (2"The Tan Sheet" Dec. 24, 2001, p. 5)...
You may also be interested in...
Nicotine Lollipops Active Ingredient Nicotine Salicylate “Illegal” – FDA
The Professional Compounding Centers of America is urging its members to switch from nicotine salicylate to nicotine polacrilex when compounding lollipops to help patients quit smoking
Ariva Tobacco Lozenges Outside FDA Purview, Marketer Maintains
Allegations Ariva tobacco lozenges make implicit drug claims are without legal merit, Star Scientific maintains in response to a Dec. 18 1petition jointly filed by 18 public health organizations. The petition urges FDA to regulate the lozenges as either a food or a drug
Sanofi Prepares Pulmonologists As Dupixent Nears COPD Finishing Line
The French drugmaker has identified education as a key challenge ahead of its June action date for the huge-selling IL4/IL-13 inhibitor in the lung condition. An approval would make it the first biologic for the disease.